| 1 |
35128264 | Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures. | 2022 Feb 1 |
2 |
| 2 |
33846339 | Association of preoperative seizures with tumor metabolites quantified by magnetic resonance spectroscopy in gliomas. | 2021 Apr 12 |
1 |
| 3 |
34610989 | Tissue 2-Hydroxyglutarate and Preoperative Seizures in Patients With Diffuse Gliomas. | 2021 Nov 23 |
1 |
| 4 |
31960518 | Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level. | 2020 Mar |
5 |
| 5 |
32958546 | Glutamate Is a Noninvasive Metabolic Biomarker of IDH1-Mutant Glioma Response to Temozolomide Treatment. | 2020 Nov 15 |
2 |
| 6 |
31139406 | Isocitrate dehydrogenase 1-mutated cancers are sensitive to the green tea polyphenol epigallocatechin-3-gallate. | 2019 |
4 |
| 7 |
31504231 | Friend or foe-IDH1 mutations in glioma 10 years on. | 2019 Nov 25 |
1 |
| 8 |
29662077 | Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate. | 2018 Apr 16 |
1 |
| 9 |
29076421 | Seizures and Anticonvulsants in Brain Tumours: Frequency, Mechanisms and Anti-Epileptic Management. | 2017 |
1 |
| 10 |
26970248 | MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T. | 2016 Oct |
1 |
| 11 |
27154922 | Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. | 2016 Nov |
6 |
| 12 |
25706986 | Metabolic reprogramming in mutant IDH1 glioma cells. | 2015 |
1 |
| 13 |
25908561 | Conditions for (13)C NMR detection of 2-hydroxyglutarate in tissue extracts from isocitrate dehydrogenase-mutated gliomas. | 2015 Jul 15 |
2 |
| 14 |
26045167 | IDH1 Mutation Induces Reprogramming of Pyruvate Metabolism. | 2015 Aug 1 |
1 |
| 15 |
26478444 | Seizures in oligodendroglial tumors. | 2015 |
1 |
| 16 |
24590270 | Quantitative metabolome analysis profiles activation of glutaminolysis in glioma with IDH1 mutation. | 2014 Jun |
1 |
| 17 |
24747768 | Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers? | 2014 Aug |
1 |
| 18 |
24876103 | Hyperpolarized [1-13C] glutamate: a metabolic imaging biomarker of IDH1 mutational status in glioma. | 2014 Aug 15 |
2 |
| 19 |
24903073 | IDH1 mutation is associated with seizures and protoplasmic subtype in patients with low-grade gliomas. | 2014 Sep |
1 |
| 20 |
25074540 | Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas. | 2014 Dec |
1 |
| 21 |
25225364 | Hominoid-specific enzyme GLUD2 promotes growth of IDH1R132H glioma. | 2014 Sep 30 |
2 |
| 22 |
25398942 | Response to "Tumor cells in search for glutamate: an alternative explanation for increased invasiveness of IDH1 mutant gliomas". | 2014 Dec |
1 |
| 23 |
23090985 | Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. | 2012 Dec |
2 |
| 24 |
11087384 | Redesigning the substrate specificity of an enzyme: isocitrate dehydrogenase. | 2000 Nov 21 |
1 |